A recent study has found that individuals prescribed medications for anxiety, depression, and sleep disorders may face a higher risk of developing Amyotrophic Lateral Sclerosis (ALS), a severe neurological disease. The research, conducted in Sweden, analyzed data from over 1,000 ALS patients and more than 5,000 healthy individuals using the Swedish Motor Neuron Disease Quality Registry. The average participant age was 67.5 years, with just over half being male.
-
: People who used anxiolytics (for anxiety), hypnotics and sedatives (for sleep), and antidepressants were more likely to be diagnosed with ALS later in life.
-
: Those who used these medications before an ALS diagnosis experienced a faster progression of the disease and lower survival rates.
-
: Experts caution that the findings show an association, not direct causation. The medications are often prescribed for symptoms—like anxiety, sleep disturbances, or depression—that may appear during the early, subtle phase of ALS, before a formal diagnosis.
-
: Some neurologists suggest these medications act on the brain’s inhibitory pathways, possibly interfering with motor neuron activity. Long-term, consistent use could have a toxic effect, though this is not confirmed.
-
: Observational studies indicate that individuals using anxiety or depression medications for more than 10 years may have a stronger link to ALS, especially among younger patients. However, it is unclear whether this reflects a true biological risk or simply earlier detection due to increased medical attention.
-
Dr. M S Panduranga (Dharamshila Narayana Super-specialty Hospital) highlighted that the link might reflect early neurological changes rather than the harmful effects of the drugs themselves.
-
Dr. Manjari Tripathi (AIIMS) noted the potential for these medications to interfere with motor neuron activity.
-
Dr. Madhukar Bhardwaj (Aakash Healthcare) emphasized the association between prolonged medication use and increased ALS risk.
-
Dr. Anshu Rohatgi (Sir Ganga Ram Hospital) advised caution in prescribing these medications, especially to those showing signs of neurological disease.
Doctors strongly advise patients not to discontinue any prescribed medications without consulting their healthcare provider. If there are concerns about the risks, a discussion with a medical professional is essential to weigh the benefits and risks in each individual case.
This article is based on observational research and expert commentary. The findings represent an association and do not prove that anxiety, depression, or sleep medications cause ALS. Patients should not make changes to their medication regimen without consulting their healthcare provider. For any health concerns, always seek advice from a qualified medical professional.